Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs

Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs

One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the avail...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of medicine and surgery 2023-02, Vol.85 (2), p.122-123
Hauptverfasser: Gulumbe, Bashar H, Adesola, Ridwan O
Format: Artikel
Sprache:eng
Schlagworte:
Reviews
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue 2
container_start_page 122
container_title Annals of medicine and surgery
container_volume 85
creator Gulumbe, Bashar H
Adesola, Ridwan O
description One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the availability of subpar pharmaceuticals in developing countries, with no scientific evidence as to what exactly is included in some of the prescriptions supplied there. These counterfeit and inferior pharmaceuticals are a financial burden of up to US$200 billion, causing thousands of patient deaths, endangering both individual and public health,and undermining patient trust in the healthcare system. Poor quality and counterfeit antibiotics are often disregarded as possible causes of AMR in AMR studies. Therefore, we examined the issue of fake drugs in LMICs and its possible links to the emergence and spread of AMR.
doi_str_mv 10.1097/MS9.0000000000000113
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9949790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2780485732</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-c9b7d3e4ec72171599efddd7bec78c12b5a6319f41beedaaf78667cbb253f7973</originalsourceid><addsrcrecordid>eNpdUdtKAzEQDaKoVP9AJI--tCab3U3yIkjxBhXBy3PIZbZGt7s1s1vw791ileq8zDBzzpkZDiEnnE040_L8_klP2HZwLnbIYcZyPWaK8d2t-oAcI76tMawQZan2yYEoVV5IJQ7J_BFWEWMXmzntXoG6OjaB4rLtaFtR7B12tgk2BTokWtl3oCH1c6QWhyKuIOEaaJsuLqJPrYu2pgkwrnkeaGzo7P5uikdkr7I1wvEmj8jL9dXz9HY8e7i5m17Oxj5nqht77WQQkIOXGZe80BqqEIJ0Q0N5nrnCloLrKucOIFhbSVWW0juXFaKSWooRufjWXfZuAcFD0yVbm2WKC5s-TWuj-Ttp4quZtyujda6lZoPA2UYgtR89YGcWET3UtW2g7dFkUrFcFVJkAzT_hg5_IyaoftdwZtY2mcEm89-mgXa6feIv6ccU8QV625AZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780485732</pqid></control><display><type>article</type><title>Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Gulumbe, Bashar H ; Adesola, Ridwan O</creator><creatorcontrib>Gulumbe, Bashar H ; Adesola, Ridwan O</creatorcontrib><description>One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the availability of subpar pharmaceuticals in developing countries, with no scientific evidence as to what exactly is included in some of the prescriptions supplied there. These counterfeit and inferior pharmaceuticals are a financial burden of up to US$200 billion, causing thousands of patient deaths, endangering both individual and public health,and undermining patient trust in the healthcare system. Poor quality and counterfeit antibiotics are often disregarded as possible causes of AMR in AMR studies. Therefore, we examined the issue of fake drugs in LMICs and its possible links to the emergence and spread of AMR.</description><identifier>ISSN: 2049-0801</identifier><identifier>EISSN: 2049-0801</identifier><identifier>DOI: 10.1097/MS9.0000000000000113</identifier><identifier>PMID: 36845783</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins</publisher><subject>Reviews</subject><ispartof>Annals of medicine and surgery, 2023-02, Vol.85 (2), p.122-123</ispartof><rights>2023 the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>2023 the Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-c9b7d3e4ec72171599efddd7bec78c12b5a6319f41beedaaf78667cbb253f7973</citedby><cites>FETCH-LOGICAL-c408t-c9b7d3e4ec72171599efddd7bec78c12b5a6319f41beedaaf78667cbb253f7973</cites><orcidid>0000-0001-7810-5265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949790/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949790/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36845783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gulumbe, Bashar H</creatorcontrib><creatorcontrib>Adesola, Ridwan O</creatorcontrib><title>Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs</title><title>Annals of medicine and surgery</title><addtitle>Ann Med Surg (Lond)</addtitle><description>One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the availability of subpar pharmaceuticals in developing countries, with no scientific evidence as to what exactly is included in some of the prescriptions supplied there. These counterfeit and inferior pharmaceuticals are a financial burden of up to US$200 billion, causing thousands of patient deaths, endangering both individual and public health,and undermining patient trust in the healthcare system. Poor quality and counterfeit antibiotics are often disregarded as possible causes of AMR in AMR studies. Therefore, we examined the issue of fake drugs in LMICs and its possible links to the emergence and spread of AMR.</description><subject>Reviews</subject><issn>2049-0801</issn><issn>2049-0801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdUdtKAzEQDaKoVP9AJI--tCab3U3yIkjxBhXBy3PIZbZGt7s1s1vw791ileq8zDBzzpkZDiEnnE040_L8_klP2HZwLnbIYcZyPWaK8d2t-oAcI76tMawQZan2yYEoVV5IJQ7J_BFWEWMXmzntXoG6OjaB4rLtaFtR7B12tgk2BTokWtl3oCH1c6QWhyKuIOEaaJsuLqJPrYu2pgkwrnkeaGzo7P5uikdkr7I1wvEmj8jL9dXz9HY8e7i5m17Oxj5nqht77WQQkIOXGZe80BqqEIJ0Q0N5nrnCloLrKucOIFhbSVWW0juXFaKSWooRufjWXfZuAcFD0yVbm2WKC5s-TWuj-Ttp4quZtyujda6lZoPA2UYgtR89YGcWET3UtW2g7dFkUrFcFVJkAzT_hg5_IyaoftdwZtY2mcEm89-mgXa6feIv6ccU8QV625AZ</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Gulumbe, Bashar H</creator><creator>Adesola, Ridwan O</creator><general>Lippincott Williams &amp; Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7810-5265</orcidid></search><sort><creationdate>20230201</creationdate><title>Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs</title><author>Gulumbe, Bashar H ; Adesola, Ridwan O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-c9b7d3e4ec72171599efddd7bec78c12b5a6319f41beedaaf78667cbb253f7973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gulumbe, Bashar H</creatorcontrib><creatorcontrib>Adesola, Ridwan O</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gulumbe, Bashar H</au><au>Adesola, Ridwan O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs</atitle><jtitle>Annals of medicine and surgery</jtitle><addtitle>Ann Med Surg (Lond)</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>85</volume><issue>2</issue><spage>122</spage><epage>123</epage><pages>122-123</pages><issn>2049-0801</issn><eissn>2049-0801</eissn><abstract>One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the availability of subpar pharmaceuticals in developing countries, with no scientific evidence as to what exactly is included in some of the prescriptions supplied there. These counterfeit and inferior pharmaceuticals are a financial burden of up to US$200 billion, causing thousands of patient deaths, endangering both individual and public health,and undermining patient trust in the healthcare system. Poor quality and counterfeit antibiotics are often disregarded as possible causes of AMR in AMR studies. Therefore, we examined the issue of fake drugs in LMICs and its possible links to the emergence and spread of AMR.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>36845783</pmid><doi>10.1097/MS9.0000000000000113</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-7810-5265</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2049-0801
ispartof Annals of medicine and surgery, 2023-02, Vol.85 (2), p.122-123
issn 2049-0801
2049-0801
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9949790
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Reviews
title Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A16%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Revisiting%20the%20blind%20spot%20of%20substandard%20and%20fake%20drugs%20as%20drivers%20of%20antimicrobial%20resistance%20in%20LMICs&rft.jtitle=Annals%20of%20medicine%20and%20surgery&rft.au=Gulumbe,%20Bashar%20H&rft.date=2023-02-01&rft.volume=85&rft.issue=2&rft.spage=122&rft.epage=123&rft.pages=122-123&rft.issn=2049-0801&rft.eissn=2049-0801&rft_id=info:doi/10.1097/MS9.0000000000000113&rft_dat=%3Cproquest_pubme%3E2780485732%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2780485732&rft_id=info:pmid/36845783&rfr_iscdi=true